SecBot SecBot
Insider Cluster (5 insiders) ·Filed Jun 8, 2026

CING

Cingulate Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago
Insider cluster: 5 insiders, $0.0M total
Actionable Insight • Neutral

Treat this cluster as noise. The split-level pricing anomaly and sub-$50K total are not actionable. Monitor for any subsequent 8-K on capital structure or reverse split — that would be the actual event to trade, not these tiny insider buys.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CING ▲ +10.75% at T+60d
NEUTRAL call +10.75% · α vs SPY +6.94% · entry $4.65 → $5.15
Entry = T+0 close
Jun 8, 2026
via day close
T+1d
+5.16%
call +5.16% · α +6.74%
$4.89
settled 5mo ago
T+5d
+6.02%
call +6.02% · α +3.61%
$4.93
settled 4mo ago
T+20d
+9.46%
call +9.46% · α +8.02%
$5.09
settled 4mo ago
T+60d
+10.75%
call +10.75% · α +6.94%
$5.15
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Five Cingulate insiders, including the CEO, CFO, and CMO, made open-market purchases totaling $44K over Feb 6-13, 2026. The dollar value is minuscule relative to the $61M market cap (0.07%), and the multi-price-point buys — CEO at $5.04, others at $0.10 — strongly suggest a reverse stock split adjustment or data anomaly rather than a uniform bullish bet. Despite the cluster form, the economic signal is negligible.

Key Financial Metrics

Direction
buying
Total Value
$44.0K
Insiders
5

Key Facts

  • 5 insiders bought shares in an 8-day window — CEO at $5.04/sh, 4 others at $0.10/sh
  • Total purchase value is just $44,000, only 0.07% of $61M market cap
  • Price disparity (50x) strongly suggests a reverse split adjusted the shares for the CEO trade but not others, or a data error
  • Cluster of buys is formally present, but the trivial absolute and relative dollar amounts render it non-material

Financial Impact

Infinitesimal — $44K total insider buys vs $61M market cap (0.07%). No economic signal.

dilution

Risk Factors

  • The CEO's $5.04 purchase may reflect a reverse-split-adjusted price while others at $0.10 are pre-split, making the cluster an artifact, not a coordinated signal

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CING-1780959753582
10 reports for CING
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CING — sortable, filterable
TypeNow
Oct 2, 2026
23d ago
8-K
NEUTRAL ★ 3/10
$4.75awaiting T+60—$4.98 (+4.84%)
Sep 22, 2026
4w ago
Institutional Cluster
NEUTRAL ★ 3/10
$5.15awaiting T+60—$4.98 (−3.21%)
Aug 13, 2026
10w ago
8-K
NEUTRAL ★ 4/10
$4.99awaiting T+60—$4.98 (−0.20%)
Jul 14, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$4.71 $4.87▲ +3.40%▲ +0.02%$4.98 (+5.73%)
Jun 16, 2026
18w ago
8-K
BULLISH ★ 6/10
$4.74 $5.17▲ +9.07%▲ +8.07%$4.98 (+5.06%)
Jun 8, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.65 $5.15▲ +10.75%▲ +6.94%$4.98 (+7.10%)
Mar 25, 2026
30w ago
EFFECT
NEUTRAL ★ 4/10
$6.36 $4.97▼ −21.86%▼ −35.31%$4.98 (−21.70%)
Mar 23, 2026
31w ago
S-3/A
BEARISH ★ 3/10
$6.93 $5.12▲ +26.12%▲ +39.18%$4.98 (+28.14%)
Mar 18, 2026
31w ago
DEFA14A
NEUTRAL ★ 3/10
$7.51 $4.93▼ −34.35%▼ −48.70%$4.98 (−33.69%)
Mar 18, 2026
31w ago
8-K
NEUTRAL ★ 4/10
$8.04 $5.09▼ −36.69%▼ −48.22%$4.98 (−38.06%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 8, 2026